Law360, New York (October 12, 2009) -- Two retirement funds have asked a federal judge to reopen a securities fraud class action alleging Sanofi-Aventis made misrepresentations regarding the side effects of an anti-obesity drug while it was awaiting U.S. Food and Drug Administration approval.
The City of Edinburgh Council on behalf of the Lothian Pension Fund and New England Carpenters Guaranteed Annuity Fund filed a motion in the U.S. District Court for the Southern...
